Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

The Ministry of Public Health and the Lebanese Pediatric Society urge parents to get their Children Vaccinated against Measles

 
WHO and UNICEF call for collective actions to fight measles during outbreak
 
 
February 17, 2020 – The recent measles vaccination campaign launched back in December following the outbreak that has spread across Lebanon have many parents concerned. The Ministry of Public Health, along with the Lebanese Pediatric Society, WHO and UNICEF are very concerned about certain misconstrued comments expressed over the last few weeks by parents on social media and WhatsApp messages. These comments are found to be wrong and misleading, while the only way to protect the child against measles is the vaccination.
 
Since onset in early 2018, the measles outbreak has spread to all eight Lebanese governorates, counting more than 2,000 reported cases, most prominently among children less than 10 years of age.
 
“Choosing to not vaccinate your children during the campaign not only leaves them susceptible to measles, but also exposes other children to measles,” said Dr. Walid Amar, Director General of the Ministry of Public Health. “The Ministry of Public Health, with the support of the World Health Organization and UNICEF, provides safe and effective vaccines free of charge to children through trained teams of health workers in all institutions. We urge all parents to take advice from health professionals on health issues because health policies and practices are evidenced based and not based on rumors”.
 
Measles is a serious and highly contagious disease. If not prevented, measles can cause serious complications including meningitis, severe diarrhea and dehydration, pneumonia and ear infections and even death. Measles survivors are often left with life-long disabilities, such as blindness, deafness and brain damage.
 
“It is important to vaccinate your children during the campaign. The third additional dose of the measles containing vaccine is crucial for optimal immunity and it is safe,” explained Dr. Bizri, Head of National Certification Committee (NCC).  “The cold chain at the MoPH Central Drugs Warehouse and the primary health care facilities are of optimal quality and ensure safe storage of vaccines. Finally, it is important to note that MoPH provides free vaccines to some major private sector health facilities”.
 
“The measles vaccine is safe and effective.  A child to be better protected needs to receive at least two doses of Measles, and there is no harm in receiving an additional dose. There are no reasons children should still be dying of this disease,” added Dr. Majdalani, Head of Lebanese pediatric society.
 
“Immunizations can save a child’s life and vaccines are only given to children after a long and careful review by scientists, doctors, and healthcare professionals. The only way to halt the epidemic currently is to vaccinate all children, between the age of 6 months and 10 years. The Measles vaccine protects children against avoidable lifelong complications and potentially death. No child should be left behind” said Dr Shankiti, representative of WHO office in Lebanon
 
The measles vaccine is procured by UNICEF through its Global Supply Division who is responsible for buying all vaccines and related items for global campaigns to eradicate polio, eliminate neonatal and maternal tetanus, and control measles. All vaccines procured through UNICEF are WHO pre-qualified and follow strict safety standards and quality control. WHO and UNICEF promote vaccine security by working with manufacturers to ensure there is a reliable supply of quality, affordable vaccines, and with governments to assess their vaccine requirements.
 
“UNICEF has a key role in vaccine procurement and procuring immunization supplies on behalf of around 100 countries annually,” said Yukie Mokuo, UNICEF representative in Lebanon. “For the past 25 years UNICEF has brought quality vaccine to the Ministry of Public health to vaccinate all children in Lebanon. Parents and communities are urged to take part in the upcoming measles vaccination campaign to reach every child.”
 
WHO and UNICEF are working with the ministry of Public Health to support vaccine supply and cold chain management, on-the-ground coordination, operations support and monitoring. WHO and UNICEF are also working with the MOPH to ensure clear communication to mobilize the general public aiming to achieve high turnout of all children under 10 years old for vaccination.
 
Representatives from the Ministry of Public Health, WHO, UNICEF, the Lebanese Pediatric Society regional delagates and the heads of other medical societies, stressed during the meeting on the need for commitment and active participation in the campaign, and the need to urge parents and advise them to give their children the extra dose during the campaign regardless of previous doses and that the vaccines provided by the Ministry of Public Health are safe and effective and that the cold chain in its central warehouse and in primary health care centers are of ideal quality and are subject to safe storage conditions .
 
The second phase of the national immunization campaign will be launched in April 2020 targeting children aged between 6 months to less than 10 years old.  All children will also receive vaccination with bivalent Oral Polio Vaccine. Children will be reached in primary healthcare centers/dispensaries, schools, nurseries and private clinics, as well as in Informal settlements
 
ENDS
 
 
About WHO

WHO is the directing and coordinating authority for health within the United Nations. Our aim is to improve future health prospects for people everywhere. WHO works in coordination with its 194 Member States in six regions, through more than 150 country offices, with a single-minded commitment to improve universal health. Together, we aspire to fight communicable diseases such as influenza or HIV, and noncommunicable diseases such as cancer or heart disease. We help mothers and children to survive and prosper, so that they have every chance of reaching a healthy old age. We monitor the safety of air, food and water, and of medicines and vaccines too. Learn more about us at www.who.int
 
About UNICEF

UNICEF works in some of the world’s toughest places, to reach the world’s most disadvantaged children. Across more than 190 countries and territories, we work for every child, everywhere, to build a better world for everyone. For more information about UNICEF and our work in Lebanon visit https://www.unicef.org/lebanon/
 
Follow UNICEF Lebanon on Twitter, Facebook, Instagram and Youtube
 
 
For more information, please contact:

Ministry of Public Health
Dr. Randa Hamade, randa_ham@hotmail.com , T: +961 3 538 878
 
UNICEF
Blanche Baz, bbaz@unicef.org T. +961 03331874
 
WHO
Hala Habib, hhabib@who.int , T: +961 3870459
 
    ...
    169
    ...
ATC Name B/G Ingredients Dosage Form Price
B05BA02 LIPIDEM G Triglycerides, Medium Chain - 100g/500ml, Soya bean oil - 80g/500ml, Omega-3 acid triglicerides - 20g/500ml Injectable emulsion 2,486,109 L.L
N04AA01 BENZHEXOL G Trihexyphenidyl - 5mg 5mg Tablet, scored 533,697 L.L
C01EB15 VASTAREL B Trimetazidine - 35mg 35mg Tablet, film coated, modified release 1,053,573 L.L
C01EB15 CARMETADIN G Trimetazidine - 35mg 35mg Tablet, film coated, modified release 631,606 L.L
J01EE01 BACTRIM FORTE B Trimethoprim - 160mg, Sulfamethoxazole - 800mg Tablet 344,024 L.L
J01EE01 CO-TRIMOXAZOLE G Trimethoprim - 160mg, Sulfamethoxazole - 800mg Tablet 7,529,090 L.L
J01EE01 CO-TRIMOXAZOLE G Trimethoprim - 160mg, Sulfamethoxazole - 800mg Tablet 183,019 L.L
J01EE01 PAEDIATRIC CO-TRIMOXAZOLE MIXTURE G Trimethoprim - 40mg/5ml, Sulfamethoxazole - 200mg/5ml Suspension 190,698 L.L
L02AE04 DECAPEPTYL LP B Triptorelin (pamoate) - 11.25mg 11.25mg Injectable powder for suspension+diluent 31,761,098 L.L
L02AE04 DECAPEPTYL LP B Triptorelin (pamoate) - 3mg 3mg Injectable powder for suspension+diluent 11,778,312 L.L
L02AE04 DECAPEPTYL B Triptorelin - 0.1mg 0.1mg Injectable lyophilised powder for solution+diluent 2,366,507 L.L
L02AE04 GONAPEPTYL CR B Triptorelin - 3.75mg 3.75mg Injectable powder for suspension+diluent 12,095,730 L.L
L02AE04 GONAPEPTYL B Triptorelin acetate - 0.1mg 0.1mg Injectable solution 4,637,600 L.L
D02AX BIAFINE B Trolamine - 0.67g/100g 0.67g/100g Emulsion 524,099 L.L
S01FA06 MYDRIACYL B Tropicamide - 1% 1% Drops solution 430,030 L.L
S01FA06 TROPICIL TOP G Tropicamide - 10mg/ml 10mg/ml Drops solution 200,233 L.L
G04BD09 SPASMEX B Trospium chloride - 30mg 30mg Tablet, film coated 2,564,051 L.L
G04BD09 SPASMEX B Trospium chloride - 30mg 30mg Tablet, film coated 2,564,051 L.L
B02BD02 NOVOEIGHT BioTech Turoctocog Alfa - 500IU 500IU Injectable powder for solution+diluent 29,783,973 L.L
B02BD02 ESPEROCT BioTech Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 1000IU/Vial 1000IU/Vial Injectable powder for solution+diluent 69,025,408 L.L
B02BD02 ESPEROCT BioTech Turoctocog Alfa pegol (recombinant coagulation factor VIII) - 500IU/Vial 500IU/Vial Injectable powder for solution+diluent 38,126,657 L.L
D06AX08 TYROSUR G Tyrothricin - 1mg/g 1mg/g Gel 510,660 L.L
G03AD02 ELLAONE B Ulipristal acetate - 30mg 30mg Tablet 2,276,469 L.L
L04AA44 RINVOQ B Upadacitinib - 15mg 15mg Tablet, prolonged release 45,469,094 L.L
C02CA06 TACHYBEN G Urapidil - 25mg/5ml 25mg/5ml Injectable solution 1,439,255 L.L
G03GA04 FOSTIMON BioHuman Urofollitropin - 150IU 150IU Injectable lyophilised powder for solution+diluent 36,347,120 L.L
G03GA04 FOSTIMON BioHuman Urofollitropin - 75IU 75IU Injectable lyophilised powder for solution+diluent 15,744,000 L.L
A05AA02 URSOFALK B Ursodeoxycholic acid - 250mg 250mg Capsule 2,823,413 L.L
L04AC05 STELARA BioTech Ustekinumab - 130mg 130mg Injectable concentrate for solution 214,532,009 L.L
L04AC05 STELARA BioTech Ustekinumab - 45mg 45mg Injectable solution 143,682,251 L.L
    ...
    169
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2025